Matthew Osmond

1.4k total citations
8 papers, 157 citations indexed

About

Matthew Osmond is a scholar working on Genetics, Molecular Biology and Genetics. According to data from OpenAlex, Matthew Osmond has authored 8 papers receiving a total of 157 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Genetics, 4 papers in Molecular Biology and 2 papers in Genetics. Recurrent topics in Matthew Osmond's work include Genomics and Rare Diseases (2 papers), Epigenetics and DNA Methylation (2 papers) and Neurogenetic and Muscular Disorders Research (2 papers). Matthew Osmond is often cited by papers focused on Genomics and Rare Diseases (2 papers), Epigenetics and DNA Methylation (2 papers) and Neurogenetic and Muscular Disorders Research (2 papers). Matthew Osmond collaborates with scholars based in Canada, United States and Netherlands. Matthew Osmond's co-authors include Alex MacKenzie, Duncan S. MacKenzie, Luke Witherspoon, Martin Holčı́k, Philippe Sauthier, Ramesh Reddy, Louise Lapensée, Kurosh Rahimi, Sangeetha Mahadevan and Somayyeh Fahiminiya and has published in prestigious journals such as Journal of Clinical Investigation, The American Journal of Human Genetics and Human Mutation.

In The Last Decade

Matthew Osmond

8 papers receiving 155 citations

Peers

Matthew Osmond

MB

GENET

PHEOH

PPCH

GENET

Nadja Kokalj Vokač Slovenia

Chiara Castronovo Italy

Houda Hamdi‐Rozé France

Carrie Koval United States

Priscilla Cukier Brazil

A O'Rourke United Kingdom

Patricia Bretones France

Stacey Hume Canada

Vyne van der Schoot Netherlands

Virginie Kinet Belgium

Nadja Kokalj Vokač Slovenia

Matthew Osmond

79 ×1.0

MB

18 ×0.4

GENET

20 ×0.4

PHEOH

49 ×1.0

PPCH

62 ×1.4

GENET

Citations per year, relative to Matthew Osmond Matthew Osmond (= 1×) peers Nadja Kokalj Vokač

Countries citing papers authored by Matthew Osmond

Since Specialization

Citations

This map shows the geographic impact of Matthew Osmond's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Matthew Osmond with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Matthew Osmond more than expected).

Fields of papers citing papers by Matthew Osmond

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Matthew Osmond. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Matthew Osmond. The network helps show where Matthew Osmond may publish in the future.

Co-authorship network of co-authors of Matthew Osmond

This figure shows the co-authorship network connecting the top 25 collaborators of Matthew Osmond. A scholar is included among the top collaborators of Matthew Osmond based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Matthew Osmond. Matthew Osmond is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

8 of 8 papers shown

1.

Osmond, Matthew, Taila Hartley, Marta Gîrdea, et al.. (2022). PhenomeCentral: 7 years of rare disease matchmaking. Human Mutation. 43(6). 674–681. 11 indexed citations

2.

Bonnen, Penelope E., Robyn Lim, John J. Mitchell, et al.. (2022). Rare diseases and space health: optimizing synergies from scientific questions to care. npj Microgravity. 8(1). 58–58. 3 indexed citations

3.

Huang, Yan, Gabrielle Lemire, Lauren C. Briere, et al.. (2022). The recurrent de novo c.2011C>T missense variant in MTSS2 causes syndromic intellectual disability. The American Journal of Human Genetics. 109(10). 1923–1931. 10 indexed citations

4.

Lemire, Gabrielle, Taila Hartley, Alison Eaton, et al.. (2022). The implementation of an enhanced clinical model to improve the diagnostic yield of exome sequencing for patients with a rare genetic disease: A Canadian experience. American Journal of Medical Genetics Part A. 191(2). 338–347. 2 indexed citations

5.

Backman, Keith, Wendy Mears, Joseph de Nanassy, et al.. (2021). A splice site and copy number variant responsible for TTC25-related primary ciliary dyskinesia. European Journal of Medical Genetics. 64(5). 104193–104193. 5 indexed citations

6.

Nguyen, Ngoc Minh, Zhao‐Jia Ge, Ramesh Reddy, et al.. (2018). Causative Mutations and Mechanism of Androgenetic Hydatidiform Moles. The American Journal of Human Genetics. 103(5). 740–751. 62 indexed citations

7.

MacKenzie, Duncan S., et al.. (2011). Prolactin increases SMN expression and survival in a mouse model of severe spinal muscular atrophy via the STAT5 pathway. Journal of Clinical Investigation. 121(8). 3042–3050. 59 indexed citations

8.

MacKenzie, Duncan S., et al.. (2011). Prolactin increases SMN expression and survival in a mouse model of severe spinal muscular atrophy via the STAT5 pathway. Journal of Clinical Investigation. 121(9). 3763–3763. 5 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact